View in EDS

Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023.

Saved in:
Bibliographic Details
Title: Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023.
Authors: Hussain, Saira1 (AUTHOR) saira.hussain@influenzacentre.org, Meijer, Adam2 (AUTHOR), Govorkova, Elena A.3 (AUTHOR), Dapat, Clyde1 (AUTHOR), Gubareva, Larisa V.4 (AUTHOR), Barr, Ian G.1 (AUTHOR), Brown, Sook Kwan1 (AUTHOR), Daniels, Rod S.5 (AUTHOR), Fujisaki, Seiichiro6 (AUTHOR), Galiano, Monica5 (AUTHOR), Huang, Weijuan7 (AUTHOR), Kondor, Rebecca J.4 (AUTHOR), Lackenby, Angie8 (AUTHOR), Lewis, Nicola5 (AUTHOR), Lo, Janice9 (AUTHOR), Nguyen, Ha T.4 (AUTHOR), Patel, Mira C.4 (AUTHOR), Pereyaslov, Dmitriy10 (AUTHOR), Rattigan, Aine5 (AUTHOR), Samaan, Magdi10 (AUTHOR)
Source: Antiviral Research. Sep2025, Vol. 241, pN.PAG-N.PAG. 1p.
Database: Environment Complete
Description
ISSN:01663542
DOI:10.1016/j.antiviral.2025.106217